
Webinar: Addressing analytical challenges in biosimilar development
The route to market for biosimilars places strong emphasis on characterisation tools for establishing comparability between biosimilar and innovator products. Addressing analytical challenges in fast-forwarding biosimilar development processes requires Implementing sophisticated analytical instruments with advanced technologies. The ICH Q6B, cited by both EMA and FDA, highlights electrophoretic data as… Read More










